Literature DB >> 9731078

Involvement of donor T-cell cytotoxic effector mechanisms in preventing allogeneic marrow graft rejection.

P J Martin1, Y Akatsuka, M Hahne, G Sale.   

Abstract

Donor CD8 cells play a pivotal role in preventing allogeneic marrow graft rejection, possibly by generating cytotoxic effectors needed to eliminate recipient T cells remaining after the pretransplant conditioning regimen or by producing cytokines needed to support the growth and differentiation of hematopoietic stem cells. In the present study, we assessed the role of donor T-cell cytotoxic effector function as a mechanism for eliminating recipient CD8 cells that cause marrow graft rejection in mice. The ability to prevent rejection was minimally affected by the presence of a defect in Fas ligand binding or by the absence of granzyme B but was severely affected by the absence of perforin. Doubly mutant perforin-deficient, Fas ligand-defective CD8 cells were completely unable to prevent rejection. Our results indicate first that recipient CD8 effectors responsible for causing marrow graft rejection are sensitive to cytotoxicity mediated by both perforin- and Fas-ligand-dependent mechanisms, and second that donor T cells must have at least one functional cytotoxic mechanism to prevent allogeneic marrow graft rejection. Copyright 1998 by The American Society of Hematology.

Entities:  

Mesh:

Year:  1998        PMID: 9731078

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  15 in total

1.  CTLs respond with activation and granule secretion when serving as targets for T-cell recognition.

Authors:  Oren Milstein; David Hagin; Assaf Lask; Shlomit Reich-Zeliger; Elias Shezen; Eran Ophir; Yaki Eidelstein; Ran Afik; Yaron E Antebi; Michael L Dustin; Yair Reisner
Journal:  Blood       Date:  2010-11-02       Impact factor: 22.113

2.  Feasibility of unmanipulated haploidentical stem cell transplantation using standard GVHD prophylaxis for HLA-homozygous patients.

Authors:  Kazuhiro Ikegame; Katsuji Kaida; Satoshi Yoshihara; Masayuki Fujiwara; Kyoko Taniguchi; Ruri Kato; Takayuki Inoue; Tatsuya Fujioka; Hiroya Tamaki; Masaya Okada; Toshihiro Soma; Norihiko Kamikonya; Hiroh Saji; Shozo Hirota; Hiroyasu Ogawa
Journal:  Int J Hematol       Date:  2012-05-25       Impact factor: 2.490

3.  Granzyme B-Mediated Activation-Induced Death of CD4+ T Cells Inhibits Murine Acute Graft-versus-Host Disease.

Authors:  Wei Du; Nicholas D Leigh; Guanglin Bian; Rachel E O'Neill; Lin Mei; Jingxin Qiu; George L Chen; Theresa Hahn; Hong Liu; Philip L McCarthy; Xuefang Cao
Journal:  J Immunol       Date:  2015-09-21       Impact factor: 5.422

4.  Haploidentical HSCT for hemoglobinopathies: improved outcomes with TCRαβ+/CD19+-depleted grafts.

Authors:  Javid Gaziev; Antonella Isgrò; Pietro Sodani; Katia Paciaroni; Gioia De Angelis; Marco Marziali; Michela Ribersani; Cecilia Alfieri; Alessandro Lanti; Tiziana Galluccio; Gaspare Adorno; Marco Andreani
Journal:  Blood Adv       Date:  2018-02-13

Review 5.  The simplification of the SCT procedures in developing countries has resulted in cost-lowering and availability to more patients.

Authors:  David Gómez-Almaguer
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

6.  Blood Stem Cell Activity Is Arrested by Th1-Mediated Injury Preventing Engraftment following Nonmyeloablative Conditioning.

Authors:  Antonia M S Müller; Mareike Florek; Holbrook E K Kohrt; Natascha J Küpper; Alexander Filatenkov; Jessica A Linderman; Husein Hadeiba; Robert S Negrin; Judith A Shizuru
Journal:  J Immunol       Date:  2016-10-10       Impact factor: 5.422

Review 7.  Rapamycin-resistant effector T-cell therapy.

Authors:  Daniel H Fowler
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

8.  Cytotoxic effector function of CD4-independent, CD8(+) T cells is mediated by TNF-α/TNFR.

Authors:  Jason M Zimmerer; Phillip H Horne; Lori A Fiessinger; Mason G Fisher; Thomas A Pham; Samiya L Saklayen; Ginny L Bumgardner
Journal:  Transplantation       Date:  2012-12-15       Impact factor: 4.939

9.  Graft rejection as a Th1-type process amenable to regulation by donor Th2-type cells through an interleukin-4/STAT6 pathway.

Authors:  Jacopo Mariotti; Jason Foley; Kaitlyn Ryan; Nicole Buxhoeveden; Veena Kapoor; Shoba Amarnath; Daniel H Fowler
Journal:  Blood       Date:  2008-07-14       Impact factor: 22.113

Review 10.  The pathophysiology of acute graft-versus-host disease.

Authors:  James L M Ferrara; Kenneth R Cooke; Takanori Teshima
Journal:  Int J Hematol       Date:  2003-10       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.